What is the current role of cardiac magnetic resonance and clinical risk scores in risk stratification for hypertrophic cardiomyopathy?

30 August 2026 (17:30 - 17:45)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Perry Mark Elliott

University College London, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail

Is the arrhythmogenic right ventricular cardiomyopathy phenotype outdated for risk prediction?

Doctor A. te Riele (Utrecht, NL)

Presentation thumbnail

Genotype or phenotype or both? Current risk prediction in dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy

Associate Professor L. Crotti (Milan, IT)

Presentation thumbnail

Personalised risk stratification in cardiomyopathies: where are we now? - discussion

Access the full session

Session thumbnail

Personalised risk stratification in cardiomyopathies: where are we now?

The Event

Event poster

ESC Congress 2026

30 August 2026 17:30 CET

You may be interested in

Congress Presentation

Imaging to stratify the risk of sudden death in hypertrophic cardiomyopathy

13 April 2026

Congress Presentation

State-of-the-art lecture on predicting cardiovascular risk using multidimensional data: from healthcare records to imaging

28 August 2026

Congress Presentation

Hypertrophic cardiomyopathy in practice: case-based decisions in treatment and risk management - discussion

25 April 2026

Congress Presentation

The challenge of risk stratification in hypertrophic cardiomyopathy: clinical, genetic and imaging insights from a quaternary referral centre

27 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources